These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8212060)

  • 41. Bootstrapping the estimated latent distribution of the two-parameter latent trait model.
    Knott M; Tzamourani P
    Br J Math Stat Psychol; 2007 May; 60(Pt 1):175-91. PubMed ID: 17535586
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Coupled Monte Carlo simulation and Copula theory for uncertainty analysis of multiphase flow simulation models.
    Jiang X; Na J; Lu W; Zhang Y
    Environ Sci Pollut Res Int; 2017 Nov; 24(31):24284-24296. PubMed ID: 28889205
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Physiologically-based toxicokinetic modeling of zearalenone and its metabolites: application to the Jersey girl study.
    Mukherjee D; Royce SG; Alexander JA; Buckley B; Isukapalli SS; Bandera EV; Zarbl H; Georgopoulos PG
    PLoS One; 2014; 9(12):e113632. PubMed ID: 25474635
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bayesian calibration of process-based forest models: bridging the gap between models and data.
    Van Oijen M; Rougier J; Smith R
    Tree Physiol; 2005 Jul; 25(7):915-27. PubMed ID: 15870058
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Propagation of uncertainty in nasal spray in vitro performance models using Monte Carlo simulation: Part II. Error propagation during product performance modeling.
    Guo C; Doub WH; Kauffman JF
    J Pharm Sci; 2010 Aug; 99(8):3572-8. PubMed ID: 20564385
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Estimation of interindividual pharmacokinetic variability factor for inhaled volatile organic chemicals using a probability-bounds approach.
    Nong A; Krishnan K
    Regul Toxicol Pharmacol; 2007 Jun; 48(1):93-101. PubMed ID: 17367907
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of statistical uncertainties on Monte Carlo treatment planning.
    Ma CM; Li JS; Jiang SB; Pawlicki T; Xiong W; Qin LH; Yang J
    Phys Med Biol; 2005 Mar; 50(5):891-907. PubMed ID: 15798263
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Propagation of uncertainty in nasal spray in vitro performance models using Monte Carlo simulation: part I. Model prediction using Monte Carlo simulation.
    Guo C; Doub WH; Kauffman JF
    J Pharm Sci; 2010 Apr; 99(4):2114-22. PubMed ID: 19902528
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biological exposure indicators: quantification of biological variability using toxicokinetic modeling.
    Truchon G; Tardif R; Droz PO; Charest-Tardif G; Pierrehumbert G
    J Occup Environ Hyg; 2006 Mar; 3(3):137-43. PubMed ID: 16464817
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Physiologically based toxicokinetic modeling of secondary acute myelolytic leukemia.
    Mukhopadhyay MK; Nath D
    Environ Toxicol Pharmacol; 2014 Jan; 37(1):378-89. PubMed ID: 24440606
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Harnessing the theoretical foundations of the exponential and beta-Poisson dose-response models to quantify parameter uncertainty using Markov Chain Monte Carlo.
    Schmidt PJ; Pintar KD; Fazil AM; Topp E
    Risk Anal; 2013 Sep; 33(9):1677-93. PubMed ID: 23311599
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fast direct Monte Carlo optimization using the inverse kernel approach.
    Bogner L; Alt M; Dirscherl T; Morgenstern I; Latscha C; Rickhey M
    Phys Med Biol; 2009 Jul; 54(13):4051-67. PubMed ID: 19502701
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Parameter sensitivity and uncertainty of the forest carbon flux model FORUG: a Monte Carlo analysis.
    Verbeeck H; Samson R; Verdonck F; Lemeur R
    Tree Physiol; 2006 Jun; 26(6):807-17. PubMed ID: 16510397
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A population-based exposure model for benzene.
    MacIntosh DL; Xue J; Ozkaynak H; Spengler JD; Ryan PB
    J Expo Anal Environ Epidemiol; 1995; 5(3):375-403. PubMed ID: 8814777
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Monte Carlo maximum likelihood method for estimating uncertainty arising from shared errors in exposures in epidemiological studies of nuclear workers.
    Stayner L; Vrijheid M; Cardis E; Stram DO; Deltour I; Gilbert SJ; Howe G
    Radiat Res; 2007 Dec; 168(6):757-63. PubMed ID: 18088178
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of statistical uncertainty on inverse treatment planning based on Monte Carlo dose calculation.
    Jeraj R; Keall P
    Phys Med Biol; 2000 Dec; 45(12):3601-13. PubMed ID: 11131187
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantification of the uncertainties of a biological model and their impact on variable RBE proton treatment plan optimization.
    Resch AF; Landry G; Kamp F; Cabal G; Belka C; Wilkens JJ; Parodi K; Dedes G
    Phys Med; 2017 Apr; 36():91-102. PubMed ID: 28410691
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Physiologically based pharmacokinetic modeling of benzene metabolism in mice through extrapolation from in vitro to in vivo.
    Cole CE; Tran HT; Schlosser PM
    J Toxicol Environ Health A; 2001 Mar; 62(6):439-65. PubMed ID: 11289318
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of different uncertainty techniques in urban stormwater quantity and quality modelling.
    Dotto CB; Mannina G; Kleidorfer M; Vezzaro L; Henrichs M; McCarthy DT; Freni G; Rauch W; Deletic A
    Water Res; 2012 May; 46(8):2545-58. PubMed ID: 22402270
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparison of methods to calculate biological effectiveness (RBE) from Monte Carlo simulations.
    Taschereau R; Roy R; Pouliot J
    Med Dosim; 2003; 28(1):21-6. PubMed ID: 12747614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.